Iovance Biotherapeutics, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 179 | 0.0% | 65,451 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 142 | 0.0% | 65,451 | 9/30/2025 |
| 2025 Q2 | 8/13/2025 | 113 | 0.0% | 65,451 | 6/30/2025 |
| 2025 Q1 | 5/12/2025 | 218 | 0.0% | 65,451 | 3/31/2025 |
| 2024 Q4 | 2/10/2025 | 484 | 0.0% | 65,451 | 12/31/2024 |
| 2024 Q3 | 11/8/2024 | 615 | 0.0% | 65,451 | 9/30/2024 |
| 2024 Q2 | 8/8/2024 | 525 | 0.0% | 65,451 | 6/30/2024 |
| 2024 Q1 | 5/8/2024 | 295 | 0.0% | 48,311 | 3/31/2024 |
| 2023 Q4 | 2/9/2024 | 532 | 0.0% | 65,451 | 12/31/2023 |
| 2023 Q3 | 11/8/2023 | 298 | 0.0% | 65,451 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 416 | 0.0% | 59,061 | 6/30/2023 |
| 2023 Q1 | 6/14/2023 | 295 | 0.0% | 48,311 | 3/31/2023 |
| 2022 Q4 | 6/14/2023 | 309 | 0.0% | 48,311 | 12/31/2022 |
| 2022 Q3 | 11/8/2022 | 519 | 0.0% | 54,131 | 9/30/2022 |
| 2022 Q2 | 8/5/2022 | 598 | 0.0% | 54,131 | 6/30/2022 |
| 2022 Q1 | 5/6/2022 | 3,490 | 0.0% | 209,602 | 3/31/2022 |
| 2021 Q4 | 2/8/2022 | 3,998 | 0.0% | 209,449 | 12/31/2021 |
| 2021 Q3 | 11/8/2021 | 5,157 | 0.0% | 209,128 | 9/30/2021 |
| 2021 Q2 | 8/10/2021 | 5,582 | 0.0% | 214,526 | 6/30/2021 |
| 2021 Q1 | 5/10/2021 | 5,197 | 0.0% | 164,138 | 3/31/2021 |
| 2020 Q4 | 2/8/2021 | 7,731 | 0.0% | 166,618 | 12/31/2020 |
| 2020 Q3 | 11/9/2020 | 5,458 | 0.0% | 165,805 | 9/30/2020 |
| 2020 Q2 | 8/7/2020 | 4,503 | 0.0% | 164,035 | 6/30/2020 |
| 2020 Q1 | 5/5/2020 | 1,469 | 0.0% | 49,072 | 3/31/2020 |
| 2019 Q4 | 2/3/2020 | 1,134 | 0.0% | 40,982 | 12/31/2019 |